Malignant Neoplasms of Lip Oral Cavity and Pharynx Recruiting Phase 1 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0081505 (Malignant Neoplasms of Lip Oral Cavity and Pharynx)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03420963Ex-Vivo Expanded Allogeneic NK Cells For The Treatment Of Pediatric Solid TumorsTreatment